Official announcement from national VA:
“This week, VA’s Office of Research and Development published three news briefs highlighting research findings on the effects of Gulf War exposures on heart disease risk, increasing non-VA prescriptions, and a potential new leukemia treatment.
Gulf War exposures led to higher heart disease risk – Researchers with the VA Center for Innovations in Quality, Effectiveness, and Safety led a team that linked toxic exposures during deployments to an increased risk for atherosclerotic cardiovascular diseases (ASCVD) in Gulf War Veterans.
Facilities outside VA give Veterans more prescriptions – VA Pittsburgh researchers found the number of prescriptions from non-VA, urgent care facilities to Veterans increased dramatically between 2019 and 2023, raising concerns about safety and compliance.
Possible new leukemia treatment found – VA researchers from the Rocky Mountain Regional VA Medical Center and the University of Colorado proved blocking a protein called STAT3 can lead to the death of acute myeloid leukemia (AML) cells, a rare but aggressive blood and bone marrow cancer.”
For more details and links to the research findings, please view the full post at the VA website.
